TY  - GEN
AU  - Halpern,Wendy G
AU  - Ameri,Mehrdad
AU  - Bowman,Christopher J
AU  - Elwell,Michael R
AU  - Mirsky,Michael L
AU  - Oliver,Julian
AU  - Regan,Karen S
AU  - Remick,Amera K
AU  - Sutherland,Vicki L
AU  - Thompson,Kary E
AU  - Tremblay,Claudine
AU  - Yoshida,Midori
AU  - Tomlinson,Lindsay
TI  - Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development
SN  - 1533-1601
PY  - 2017///1201
KW  - Animals
KW  - Drug Evaluation, Preclinical
KW  - methods
KW  - Guideline Adherence
KW  - Humans
KW  - Pathology, Clinical
KW  - Toxicity Tests
KW  - Toxicology
N1  - Publication Type: Journal Article; Research Support, N.I.H., Intramural
UR  - https://doi.org/10.1177/0192623316650052
ER  -